3 terminated. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
| Phase 2 | 1 | Terminated 1 |
Follow TP protocol: new trials by email Literature Review of TP protocol trials Research Report on TP protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer S-1 and Paclitaxel, Paclitaxel and Cisplatin, 5-FU and Cisplatin - Esophageal Cancer | Phase 2 / Phase 3 | Terminated | Peking University | 4 | 2012-08-01 | 2017-04-07 |
| Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer Paclitaxel/Cisplatin, Reduced RT, 5-FU/Cisplatin - Head and Neck Cancer | Phase 3 | Terminated | University of Erlangen-Nürnberg Medical School | 221 | 2010-06-01 | 2021-05-04 |
| ERCC1 Targeted Trial Cisplatin, Paclitaxel - Lung Cancer | Phase 3 | Terminated | University College, London | 648 | 2009-10-01 | 2013-12-10 |
Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1)
Peking University (1) · University College, London (1) · University of Erlangen-Nürnberg Medical School (1)
China (1) · Germany (1) · United Kingdom (1)
Rainer Fietkau, MD (1) · Siow M. Lee, MD, PhD, FRCP (1) · Xiaodong Zhang, MD (1)
2005 (1)